A comparison of once-daily triamcinolone acetonide aqueous and twice-daily beclomethasone dipropionate aqueous nasal sprays in the treatment of seasonal allergic rhinitis.

@article{Lumry2003ACO,
  title={A comparison of once-daily triamcinolone acetonide aqueous and twice-daily beclomethasone dipropionate aqueous nasal sprays in the treatment of seasonal allergic rhinitis.},
  author={William Raymond Lumry and Frank Hampel and Craig Laforce and Frederic Kiechel and Tarek el-Akkad and John J. Murray},
  journal={Allergy and asthma proceedings},
  year={2003},
  volume={24 3},
  pages={203-10}
}
Ragweed pollen is the most frequent cause of allergic rhinitis in the late summer-fall in North America. The objectives of this multicenter, randomized, single-blind study are to assess the efficacy and safety of triamcinolone acetonide aqueous (TAA AQ) and beclomethasone dipropionate aqueous (BDP) in the treatment of adult patients with seasonal ragweed-induced allergic rhinitis. Patient's self-assessment of comfort with medication and health-related quality of life were also assessed. A total… CONTINUE READING